Christophe Weber, Takeda president and CEO (AP Images)
Takeda gets a $2.2B deal for its OTC unit as debt-relief drive nears its end
In a big step toward its $10 billion divestment goal, Takeda struck a deal to sell its Japanese consumer healthcare business, known for over-the-counter products …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
